Effect of bilinaster drop on the neonatal juandice
Phase 3
- Conditions
- neonatal jaundice.Neonatal jaundice, unspecified
- Registration Number
- IRCT2015050622115N1
- Lead Sponsor
- Sabzevar University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Gestational age 35-42week, birth weight over 2000 grams, total bilirubin>17mg/dl . exclusively breast feeding, lack of photo therapy or other therapies before hospitalisation, jaundice with unknown cause (idiopathic), birth Apgar score>7.
Exclusion criteria: Jaundice with known cause (pathological). direct bilirubin >2, Indications for blood exchange transfusion, severe congenital defects, eclampsia / preeclampsia, asphyxia, transient or mild respiratory distress , sepsis ,hemolytic hyperbilirubinemia
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total bilirubin. Timepoint: Before the intervention, then every 12 hours for 48 hours after the intervention. Method of measurement: The hospital laboratory and by divice autoanalyzer.
- Secondary Outcome Measures
Name Time Method